The SUSTAIN-6 trial, which tracked over 3,000 patients on semaglutide for nearly three years, documented improvements in kidney function markers across multiple dose levels
Poornima I, Brown SB, Bhashyam S, Parikh P, Bolukoglu H, Shannon RP: Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat
During Treatment: The injection is typically administered intramuscularly, often in the upper arm or thigh (common injection sites)
This personalized insight helps your provider fine-tune your dose and medication choice before travel, ensuring maximum effectiveness throughout your trip
Patel, A., Gandhi, H., & Upaganlawar, A